InMode (INMD) Gross Margin (2018 - 2026)
InMode (INMD) posted quarterly Gross Margin of 75.05% for Q1 2026, down 317.0% year-on-year from 34.58% in Q1 2025, and down 4.13% on a QoQ basis from 78.28% in Q4 2025.
InMode (INMD) Gross Margin (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Gross Margin for 9 consecutive years, with 75.05% the latest figure, recorded in Q1 2026.
- Quarterly Gross Margin fell 317.0% year-over-year to 75.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 77.84% (down 220.0% YoY) and the FY2025 annual result came in at 78.54%, down 177.0% from the prior year.
- Gross Margin retreated to 75.05% in Q1 2026 per INMD's latest filing, from 78.28% in the prior quarter.
- Over the last five years, Gross Margin for INMD reached as high as 84.52% in Q3 2022 and fell as low as 75.05% in Q1 2026.
- A 5-year average of 81.12% and a median of 81.53% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin soared 48 bps — and 2024, when it sank 468 bps.
- Year by year, Gross Margin stood at 84.28% in 2022, then declined by 0 bps to 84.02% in 2023, then slipped by 6 bps to 79.34% in 2024, then dropped by 1 bps to 78.28% in 2025, then fell by 4 bps to 75.05% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 75.05%, 78.28%, and 77.61% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 75.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.05% |
| Dec 31, 2025 | 78.28% |
| Sep 30, 2025 | 77.61% |
| Jun 30, 2025 | 79.97% |
| Mar 31, 2025 | 78.22% |
| Dec 31, 2024 | 79.34% |
| Sep 30, 2024 | 81.53% |
| Jun 30, 2024 | 80.20% |
| Mar 31, 2024 | 79.62% |
| Dec 31, 2023 | 84.02% |
| Sep 30, 2023 | 83.64% |
| Jun 30, 2023 | 83.79% |
| Mar 31, 2023 | 82.79% |
| Dec 31, 2022 | 84.28% |
| Sep 30, 2022 | 84.52% |
| Jun 30, 2022 | 83.31% |
| Mar 31, 2022 | 82.81% |
| Dec 31, 2021 | 84.76% |
| Sep 30, 2021 | 85.19% |
| Jun 30, 2021 | 85.43% |